FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide president of the BD Medication Management Solutions business unit, effective October 1.

新泽西州富兰克林湖（2024年10月1日）–全球领先的医疗技术公司BD（Becton，Dickinson and Company）（纽约证券交易所：BDX）今天宣布，康纳·贝茨（Connor Bates）被任命为BD药物管理解决方案业务部门的全球总裁，自10月1日起生效。

In this role, Bates will be responsible for driving the global strategic, operational, quality and commercial excellence of the Medication Management Solutions business unit. He will be based out of San Diego and report to Mike Garrison, executive vice president and president of the BD Medical Segment..

在这个职位上，贝茨将负责推动药物管理解决方案业务部门的全球战略，运营，质量和商业卓越。他将驻扎在圣地亚哥，向执行副总裁兼BD医疗部门总裁迈克·加里森报告。。

Bates joined BD in 1995 and has made significant contributions through successive roles in marketing, strategic planning, supply chain management, product development, process engineering and manufacturing operations. Since 2019, he has served as vice president and general manager for the worldwide Infusion Solutions business within the Medication Management Solutions business unit.

贝茨于1995年加入BD，通过在市场营销、战略规划、供应链管理、产品开发、工艺工程和制造运营中的历任角色，做出了重大贡献。自2019年以来，他一直担任药物管理解决方案业务部门全球输液业务的副总裁兼总经理。

Earlier in his career, Bates held leadership positions within BD Biosciences in the life science research tools and clinical diagnostics businesses..

在职业生涯早期，贝茨曾在BD Biosciences担任生命科学研究工具和临床诊断业务的领导职位。。

“Connor is a proven leader who brings a strong track record of results and decades of broad cross-functional experience across the enterprise, including deep knowledge of the Medication Management Solutions business and our infusion platforms,” said Garrison. “This unique insight and expertise will be invaluable as we remain laser-focused on the relaunch of the BD Alaris™ Infusion System and accelerate growth across all of our connected medication management platforms throughout the care continuum.”.

加里森说：“康纳是一位久经考验的领导者，他在整个企业中取得了良好的业绩记录和数十年的广泛跨职能经验，包括对药物管理解决方案业务和我们的输液平台的深入了解。”。“这种独特的见解和专业知识将是非常宝贵的，因为我们仍然专注于重新启动BD Alaris™输液系统，并在整个护理过程中加速我们所有相关药物管理平台的增长。”。

Bates holds a B.S. in Mechanical Engineering from Kettering University and an MBA from Harvard Business School.

贝茨拥有凯特琳大学机械工程学士学位和哈佛商学院工商管理硕士学位。

About BD

关于BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

BD是世界上最大的全球医疗技术公司之一，正在通过改进医疗发现、诊断和护理服务来推动世界健康。该公司通过开发创新技术、服务和解决方案来支持医疗保健前线的英雄，这些技术、服务和解决方案有助于推进患者的临床治疗和医疗保健提供者的临床过程。

BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.

BD及其70000多名员工充满热情并致力于帮助提高临床医生护理过程的安全性和效率，使实验室科学家能够准确检测疾病，并提高研究人员开发下一代诊断和治疗方法的能力。

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD在几乎每个国家都有业务，并与世界各地的组织合作，以解决一些最具挑战性的全球健康问题。通过与客户密切合作，BD可以帮助提高成果，降低成本，提高效率，提高安全性并扩大医疗保健的范围。

For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. .

有关BD的更多信息，请访问BD.com或通过LinkedIn与我们联系，网址为www.LinkedIn.com/company/bd1/，X（以前的Twitter）@BDandCo或Instagram@becton\u dickinson。。

Contacts:

联系人：

Media:                                                                                                                  Investors:

媒体：投资者：

Troy Kirkpatrick                                                                                                  Adam Reiffe

特洛伊·柯克帕特里克·亚当·瑞夫

VP, Public Relations                                                                                           Sr. Director, Investor Relations

公共关系副总裁。投资者关系总监

858.617.2361                                                                                                    201.847.6927

858.617.2361                                                                                                    201.847.6927

troy.kirkpatrick@bd.com                                                                                 adam.reiffe@bd.com

troy.kirkpatrick@bd.com对不起，对不起。adam.reiffe@bd.com